Transcat, Inc.

NASDAQ:TRNS

Industrial - Distribution

Industrials
$100.12 +2.19%

+$2.00 today

Market cap
$941.61M
Beta
0.70
P/E (TTM)
150.2
EPS (TTM)
$0.62
52W Low $50.23High $94.76

Volume 0.11M

Average 0.16M

TRNS Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Transcat, Inc.NASDAQ: TRNS

Net Income · Q4 FY2025 · quarter ended Mar 2026

Net income declines year over year

Q4 FY2025 net income of $1.95M fell 56.4% year over year, ahead of the -63.0% change in trailing-twelve-month net income. Over 3 fiscal years it compounded at -20.5% a year.

Context

  • Net income amounted to 1.6% of revenue in FY2025, down 3.6 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 4 analysts of $20.42M (+279.9%) for the fiscal year ending Mar 2027, a step up from the -63.0% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.95M+276.8% QoQ
Last fiscal yearMar 2026
$5.38M-63.0% YoY
LTMMar 2026
$5.38M-63.0% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-56.4%+10.5%+66.9 pp
1 year-63.0%+279.9%+342.8 pp
3-year CAGR-20.5%+68.8%+89.3 pp
5-year CAGR+45.0%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
5.38M USD
Year-over-year change
-63.0%
4-year CAGR
-17.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How TRNS compares with its peers on the latest reported figures

  • TRNS's LTM Mar 2026 net income of $5.38M is the 10th largest of the 11 companies compared; the peer median is $10.07M.
  • Its year-over-year change of -63.0% is the 10th highest of 11, against a peer median of +8.4%.
  • Net income amounts to 1.6% of revenue for TRNS, versus a peer median of 12.7%.
TRNS Competitors Peer median
Net Income for TRNS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QDELQuidelOrtho CorporationLTM Mar 2026$1.21B +237.6%—45.6%
MTDMettler-Toledo International Inc.LTM Jun 2026$905.61M +9.1%-0.1%21.9%
TECHBio-Techne CorporationLTM Sep 2026$171.97M +120.5%-14.0%14.0%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$162.3M +36.7%—6.3%
TICTIC Solutions, Inc.LTM Jun 2026$120.52M -14.2%—5.9%
LABStandard BioTools Inc.LTM Mar 2026$78.21M +158.9%-26.7%90.7%
UFPTUFP Technologies, Inc.LTM Jun 2026$72.3M +7.7%+17.8%11.4%
NEONeoGenomics, Inc.LTM Jun 2026$51.88M -50.1%-9.2%6.8%
TKNOAlpha Teknova, Inc.LTM Mar 2026$17.17M -26.3%-28.6%41.1%
TRNSTranscat, Inc.LTM Mar 2026$5.38M -63.0%-20.5%1.6%
BLFSBioLife Solutions, Inc.LTM Mar 2026$2.96M -87.7%-68.0%3.0%
Peer median (excluding TRNS) $10.07M+8.4%-14.0%12.7%

Competitors are the stored peer set for TRNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income11.38M10.69M13.65M14.52M5.38M
Depreciation & Amortization9.57M10.96M13.54M18.57M26.17M
Deferred Income Tax559K(186K)(1.6M)(5K)827K
Stock-Based Compensation2.33M3.38M4.51M3.25M7.55M
Change in Working Capital(6.34M)(8.05M)2.05M3.21M(11.9M)
Accounts Receivables(3.39M)74K406K(1.29M)(6.58M)
Inventory(122K)(3.38M)2.32M4.39M839K
Accounts Payables1.9M1.6M(5.01M)4.94M965K
Other Working Capital(4.73M)(6.34M)4.33M(4.83M)(7.13M)
Other Non-Cash Items122K162K459K(550K)6.83M
Operating Cash Flow17.62M16.95M32.62M38.99M34.85M
Capital Expenditures(10.15M)(9.41M)(13.28M)(13.2M)(15.3M)
Acquisitions (Net)(29.81M)(9.11M)(12.86M)(87.44M)(82.53M)
Purchases of Investments00(15.53M)00
Sales of Investments00000
Other Investing Activities109K10K016.63M0
Investing Cash Flow(39.85M)(18.51M)(41.67M)(84M)(97.82M)
Debt Repayment28.89M665K(44.96M)28.55M66.41M
Common Stock Issued1.49M658K77.27M1.87M842K
Common Stock Repurchased(6.68M)(447K)(4.91M)(3.57M)(469K)
Dividends Paid00000
Other Financing Activities0000(280K)
Financing Cash Flow23.69M876K27.4M26.86M66.5M
Effect of Forex Changes(625K)821K(228K)24K(103K)
Net Change in Cash836K135K18.12M(18.13M)3.43M
Free Cash Flow7.47M7.54M19.34M25.79M19.55M

Transcat, Inc.

NASDAQ:TRNS

Intrinsic Alpha fair value

Locked

Current Price

$100.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.